ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 147

Familial Clustering of Immune-mediated Diseases in Children with Abrupt-onset OCD

Avis Chan 1, Tiffany Phu 1, Bahare Farhadian 2, Theresa Willett 3, Melissa Silverman 1, Paula Tran 1, Margo Thienemann 3 and Jennifer Frankovich4, 1Stanford University School of Medicine, Palo Alto, 2Stanford Immune Behavioral Health Clinic and PANS Research Program at Lucile Packard Children's Hospital, Palo Alto, 3Stanford University School of Medicine, Palo Alto, California, 4Stanford

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: autoimmune diseases, family studies, Obsessive compulsive disorder, PANS

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Saturday, May 2, 2020

Title: Poster Session 3

Session Type: ACR Abstract Session

Session Time: 4:15PM-5:15PM

Background/Purpose: Recent epidemiologic studies have reported increased rates of immune-mediated comorbidities among first-degree relatives of patients with OCD and tic disorders.(Mataix-Cols et al., Mol Psychiatry 2018; Westwell-Roper et al., Mol Psychiatry 2019) However, these studies were limited by the lack of healthy control data, and they asked for a replication study. In this study, we aimed to compare the prevalence rates of immune-mediated diseases in siblings and parents of children with abrupt-onset OCD and healthy controls. We define abrupt-onset OCD as sudden-onset OCD which develops to full symptom severity within 72 hours, and is diagnosed by a psychiatrist. Many children diagnosed with this type of OCD also meet the diagnostic criteria of Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) which is characterized by abrupt-onset OCD and/or severe eating restriction, and other neuropsychiatric symptoms.(Swedo et al., Pediatr Therapeut 2012)

Methods: This was a retrospective cross-sectional study approved by the IRB. We included patients from our multidisciplinary PANS clinic between September 2012 and June 2019, who presented with abrupt-onset OCD. We excluded adopted patients with unclear history. We also recruited healthy children of the same age range, from the same community. Patients’ and healthy controls’ families complete an intake questionnaire which queries family history of immune-mediated diseases and psychiatric disorders. From the questionnaire answers, we examined their demographic characteristics and prevalence rates of OCD and immune-mediated diseases in their first-degree relatives (sibling and parents) by descriptive statistics and appropriate tests like Chi-square or Fisher’s exact tests.

Results: This study included 244 consecutive patients and 121 healthy controls (Fig.1). Our study patients had a mean age of symptom onset at 8.6 (SD 3.6) years and a mean age of clinic presentation at 10.6 (SD 4.2) years; 61% were males and 78% were White; Mean CYBOCS at initial clinic presentation was 17.3 (SD 10.0). Healthy controls presented to us at older age (mean 12.4, SD 4.4 years), and a lower proportion (52%) was White. Otherwise, patients and healthy controls were demographically similar. We found OCD more prevalent in siblings (16% vs 1%, p< 0.001) and parents of our patients (12% vs 3%, p< 0.01) than those of healthy controls (Table 1). As well, siblings and parents of patients reported more immune-mediated diseases than those of healthy controls with statistical significance after adjusting for race and age at clinic presentation (adjusted OR 2.80, 95% CI, 1.64-4.76, p< 0.001). The study was underpowered to show statistically significant differences in each specific disease.

Conclusion: Our findings of an increased risk of having immune-mediated disorders in first degree relatives of our patients with early abrupt-onset OCD are in line with other studies looking at the general OCD population. When seeing patients with both abrupt-onset OCD and idiopathic OCD, we should carefully evaluate families for immune disorders.

Table 1. Lifetime prevalence of obsessive compulsive disorder (OCD) and immune_mediated comorbidities in first degree family members of patients and healthy controls included in the study.

Figure 1. Inclusion and exclusion flowchart for the study.


Disclosure: A. Chan, None; T. Phu, None; B. Farhadian, None; T. Willett, None; M. Silverman, None; P. Tran, None; M. Thienemann, None; J. Frankovich, None.

To cite this abstract in AMA style:

Chan A, Phu T, Farhadian B, Willett T, Silverman M, Tran P, Thienemann M, Frankovich J. Familial Clustering of Immune-mediated Diseases in Children with Abrupt-onset OCD [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/familial-clustering-of-immune-mediated-diseases-in-children-with-abrupt-onset-ocd/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/familial-clustering-of-immune-mediated-diseases-in-children-with-abrupt-onset-ocd/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology